M&T BANK CORP - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 180 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$472,163
-10.1%
8,623
+37.9%
0.00%0.0%
Q2 2023$525,309
+28.8%
6,255
+16.3%
0.00%0.0%
Q1 2023$407,714
-79.3%
5,380
-56.2%
0.00%
-50.0%
Q4 2022$1,966,755
+455.6%
12,280
+44.5%
0.00%
+100.0%
Q3 2022$354,000
-65.4%
8,498
-72.5%
0.00%
-60.0%
Q3 2021$1,022,000
-8.1%
30,900
-7.8%
0.01%0.0%
Q2 2021$1,112,000
+34.0%
33,506
+67.5%
0.01%
+25.0%
Q1 2021$830,00020,0060.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2022
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders